Stockreport

Halozyme (HALO) Boosted by ENHANZE Launches and Analyst Upgrade [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF Halozyme Therapeutics, Inc. (NASDAQ:HALO) price target from $79 to $90 while maintaining a Buy rating on the company's shares. The firm stated that Halozyme Therapeutics [Read more]